RELEASE OF ANTIINFLAMMATORY MEDIATORS AFTER MECHANICAL TRAUMA CORRELATES WITH SEVERITY OF INJURY AND CLINICAL OUTCOME

被引:100
作者
ERTEL, W
KEEL, M
BONACCIO, M
STECKHOLZER, U
GALLATI, H
KENNEY, JS
TRENTZ, O
机构
[1] UNIV ZURICH,DEPT SURG,DIV TRAUMA SURG,ZURICH,SWITZERLAND
[2] F HOFFMANN LA ROCHE & CO LTD,PHARMACEUT RES,CH-4002 BASEL,SWITZERLAND
[3] SYNTEX RES,INST BIOL RES,PALO ALTO,CA
关键词
D O I
10.1097/00005373-199511000-00011
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Excessive synthesis of proinflammatory cytokines [tumor necrosis factor (TNP)-alpha and interleukin (IL)-1 beta] after trauma has been correlated with poor outcome, Recently, naturally occurring inhibitors of TNF-alpha and IL-1 beta have been characterized such as soluble TNF receptors (sTNFRs) and IL-1 receptor antagonist (IL-1ra), The present study was undertaken to determine whether injury results in a rise of circulating sTNFRs and IL-1ra, If so, whether plasma levels of these anti inflammatory mediators correlate with severity of injury and clinical outcome of these patients, Injured patients (n = 213) showed significantly increased sTNFR and IL-1ra plasma levels throughout the observation period of 14 days, compared with healthy volunteers (n = 127), Patients with severe injury (Injury Severity Score > 16 points) revealed higher levels (p < 0.05) of sTNFRs and IL-1ra than patients with minor trauma (Injury Severity Score less than or equal to 16 points), Patients who died from injury demonstrated increased (p < 0.05) sTNFR p55 and IL-1ra plasma levels, compared with survivors. Thus, anti-inflammatory mechanisms are activated after trauma dependent on severity of injury, Because increased plasma levels of anti-inflammatory reacting proteins portended poorly for patient survival, these mediators may contribute to prediction of outcome after severe injury.
引用
收藏
页码:879 / 887
页数:9
相关论文
共 60 条
  • [1] STABILIZATION OF THE BIOACTIVITY OF TUMOR-NECROSIS-FACTOR BY ITS SOLUBLE RECEPTORS
    ADERKA, D
    ENGELMANN, H
    MAOR, Y
    BRAKEBUSCH, C
    WALLACH, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) : 323 - 329
  • [2] A RECOMBINANT HUMAN RECEPTOR ANTAGONIST TO INTERLEUKIN-1 IMPROVES SURVIVAL AFTER LETHAL ENDOTOXEMIA IN MICE
    ALEXANDER, HR
    DOHERTY, GM
    BURESH, CM
    VENZON, DJ
    NORTON, JA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) : 1029 - 1032
  • [3] AREND WP, 1991, J IMMUNOL, V147, P1530
  • [4] INTERLEUKIN-1 RECEPTOR ANTAGONIST - A NEW MEMBER OF THE INTERLEUKIN-1 FAMILY
    AREND, WP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) : 1445 - 1451
  • [5] BIOLOGICAL PROPERTIES OF RECOMBINANT HUMAN MONOCYTE-DERIVED INTERLEUKIN-1 RECEPTOR ANTAGONIST
    AREND, WP
    WELGUS, HG
    THOMPSON, RC
    EISENBERG, SP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (05) : 1694 - 1697
  • [6] AREND WP, 1989, J IMMUNOL, V143, P1851
  • [7] DIFFERENTIAL ALTERATIONS IN PLASMA IL-L AND TNF LEVELS AFTER TRAUMA AND HEMORRHAGE
    AYALA, A
    WANG, P
    BA, ZF
    PERRIN, MM
    ERTEL, W
    CHAUDRY, IH
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 260 (01): : R167 - R171
  • [8] INTERLEUKIN-1 INHIBITORY ACTIVITY SECRETED BY A HUMAN MYELOMONOCYTIC CELL-LINE (M20)
    BARAK, V
    TREVES, AJ
    YANAI, P
    HALPERIN, M
    WASSERMAN, D
    BIRAN, S
    BRAUN, S
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (11) : 1449 - 1452
  • [9] THE ROLE OF THE GUT IN THE DEVELOPMENT OF MULTIPLE ORGAN DYSFUNCTION IN CARDIOTHORACIC PATIENTS
    BAUE, AE
    [J]. ANNALS OF THORACIC SURGERY, 1993, 55 (04) : 822 - 829
  • [10] THE PATHOGENESIS OF SEPSIS
    BONE, RC
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (06) : 457 - 469